药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cryptenamine
Lorcainide
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Lorcainide.
Cryptenamine
Bunaftine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Bunaftine.
Cryptenamine
Nizofenone
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Nizofenone.
Cryptenamine
Otilonium
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Otilonium.
Cryptenamine
Oxatomide
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Oxatomide.
Cryptenamine
Abexinostat
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Abexinostat.
Cryptenamine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Ricolinostat.
Cryptenamine
Simendan
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Simendan.
Cryptenamine
CUDC-101
The risk or severity of QTc prolongation can be increased when Desipramine is combined with CUDC-101.
Cryptenamine
Entinostat
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Entinostat.
Cryptenamine
Mocetinostat
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Mocetinostat.
Cryptenamine
Benidipine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Benidipine.
Cryptenamine
Fendiline
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Fendiline.
Cryptenamine
Bedaquiline
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Bedaquiline.
Cryptenamine
Antazoline
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Antazoline.
Cryptenamine
Nilvadipine
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Nilvadipine.
Cryptenamine
Tucidinostat
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Tucidinostat.
Cryptenamine
Tedisamil
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Tedisamil.
Cryptenamine
Pracinostat
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Pracinostat.
Cryptenamine
Azimilide
The risk or severity of QTc prolongation can be increased when Desipramine is combined with Azimilide.